Pathware, a Denver, CO-based MedTech company, raised $7M in Series A funding.
The round was led by UnityPoint Health Ventures and Level Eight Ventures with participation from MVolution Partners, Solas BioVentures, Sidney Taurel, Steve Laczynski, Monica Richter, David Johnson, James Watt, and Peter Faroni.
The company intends to use the funds to continue expanding the team and to submit the integrated hardware and software system to the FDA for clearance.
Led by newly named CEO TJ Meyer, Pathware is developing hardware and software to bring digital pathology from the central lab to the point-of-care. Mr. Meyer most recently led global marketing, strategy, clinical support, and business development at Veran Medical Technologies, a medical device company focused on the early diagnosis and staging of lung cancer. During Mr. Meyer’s tenure, Veran grew revenues from $2 million to $30 million and was acquired by Olympus in December of 2020.
FinSMEs
20/04/2022